Enrolling by invitationNo phase
Long-term follow-up registry of the Endogenex System for type 2 diabetes
Collects long-term real-world information on the Endogenex System in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)
Key facts
- Where
- Houston, Quincy, and Raleigh, United StatesSee the 3 sites
Where in United States
- Care AccessHouston, United StatesNo longer taking part
- Care AccessQuincy, United StatesNo longer taking part
- Care AccessRaleigh, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Endogenex, Inc.
- Trial code
- NCT07197775
- Record updated
- 1 July 2026
- Original description
This registry is designed to collect long-term data and support ongoing post-market surveillance of real-world data for the Endogenex System.Read full original descriptionShow less
Endogenex PULSE Registry
This registry is designed to collect long-term data and support ongoing post-market surveillance of real-world data for the Endogenex System.
Inclusion: Type 2 diabetes; Have been treated with the Endogenex System; Consented to participate in the Endogenex PULSE Registry.
Exclusion: Unwilling or unable to attend study visits; Unwilling or unable to provide medical records to study sites.